Dentists in Rolla, MO Accepting Medicare
31 Dentists found. Showing 21 - 31
 Ailene Invencion Kang, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1081 E 18th St, Rolla, MO 65401 Phone: 573-426-2407 |
 Dr. Nicholas Joseph Varney, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 1491 E 10th St, Rolla, MO 65401 Phone: 573-364-2868 Fax: 573-364-1089 |
Dr. Andrew James Cassidy, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1201 Forum Dr, Rolla, MO 65401 Phone: 573-364-1821 |
Stephen Vance Moorkamp, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 912 N Cedar St, Rolla, MO 65401 Phone: 573-364-1345 |
Blake Thomas Rost, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 509 E 10th St, Rolla, MO 65401 Phone: 573-426-4455 Fax: 573-426-6723 |
Dr. Emily Starr Taylor, D.D.S., M.S.D. Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 206 S Bishop Ave, Unit A, Rolla, MO 65401 Phone: 573-368-7336 |
Dr. Linda Kay Westmoreland, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 713 Salem Ave, Suite A., Rolla, MO 65401 Phone: 573-368-7325 Fax: 573-368-7326 |
Dr. William Francis Maddux, D.M.D. Dentist - Periodontics Medicare: Medicare Enrolled Practice Location: 1810 E 10th St, Rolla, MO 65401 Phone: 573-364-1821 |
Dr. Zuzanna Apel, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1201 Forum Dr, Rolla, MO 65401 Phone: 573-364-1821 |
Chloe Ann Stuck, DDS Dentist - Dental Public Health Medicare: Medicare Enrolled Practice Location: 1081 E 18th St, Rolla, MO 65401 Phone: 573-426-6712 Fax: 573-426-6735 |
Dr. Susan J Sherrick, DDS, MSD Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 711 Salem Ave, Rolla, MO 65401 Phone: 573-364-5530 Fax: 573-368-5405 |
News Archive
Study shows interferons do not induce the expression of SARS-CoV-2 cell entry receptor
In a new bioRxiv study, authors identified a isoform of ACE2 (designated as deltaACE2 or dACE2) receptor, shown to be induced in various human cell types.
Minerva Biotechnologies grants Clarient exclusive commercializing rights to its MUC1 diagnostic test
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that privately held, Waltham, MA-based Minerva Biotechnologies has granted it the exclusive right to develop and commercialize a test that identifies the MUC1* protein, a biomarker researchers believe may be implicated in the spread of many cancers, including breast cancer.
Brain neuron activity can signal initiation, termination of behavioural sequences: Study
Rui Costa, Principal Investigator of the Champalimaud Neuroscience Programme at the Instituto Gulbenkian de Ciência, and Xin Jin, of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, describe in the latest issue of the journal Nature, that the activity of certain neurons in the brain can signal the initiation and termination of behavioural sequences we learn anew. Furthermore, they found that this brain activity is essential for learning and executing novel action sequences, many times compromised in patients suffering from disorders such as Parkinson's or Huntington's.
Bayer's Ciprofloxacin DPI receives FDA orphan drug designation for NCFB treatment
Bayer HealthCare today announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation for its investigational Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) for the treatment of non-cystic fibrosis bronchiectasis (NCFB).
ODS enters license agreement with Enox Biopharma to develop novel treatment for periodontal disease
Enox Biopharma, a leader in the development of innovative solutions for infections associated with medical devices, and Ortho Dental Solutions LTD today announced an execution of an exclusive royalty bearing license agreement under which Enox Biopharma shall grant Ortho Dental Solutions LTD rights to patent application and knowhow for use in developing novel therapies limited in use for dental and gum diseases.
› Verified 5 days ago
- 1
- 2(current)
Counselors
Pharmacists
Dentists
Clinical Social Workers
Psychologists
Occupational Therapists